Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Renal Insufficiency, Chronic 1Non-alcoholic Fatty Liver Disease 1Liver Cirrhosis, Alcoholic 1Hypothermia 1Hepatitis C 1Hepatitis B 1Fibrosis 1End Stage Liver Disease 1Carcinoma, Hepatocellular 1Acute Kidney Injury 1

Interventions

Blood Specimen Collection 7Pentoxifylline 4Liver Transplantation 4Magnetic Resonance Spectroscopy 3Tocopherols 2Low-Level Light Therapy 2High-Energy Shock Waves 2tremelimumab 1sonidegib 1maltodextrin 1epigallocatechin gallate 1durvalumab 1contrast agent BR1 1bavituximab 1apixaban 1alpha-Tocopherol 1Vitamin E 1Vitamin D 1User-Centered Design 1Tenofovir 1Surveys and Questionnaires 1Sunitinib 1Standard of Care 1Spermine Synthase 1Specimen Handling 1Sorafenib 1Sonazoid 1Sodium Chloride 1Sampling Studies 1Restraint, Physical 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Fibrosis × Hypothermia, Induced × Clear all
NCT03534141 2025-05-16

MHALT

University of California, San Francisco

Phase NA Terminated
175 enrolled 19 charts
GastrointestinalGenitourinary

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hypothermia, Liver Cirrhosis, Alcoholic, Renal Insufficiency, Chronic, Acute Kidney Injury, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡